O6-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts

International Journal of Cancer

Volumn 85, Issue 2, 2000, Pages 248-252

  Middleton, Mark R ^a,b   Kelly, Jane ^a   Thatcher, Nicholas ^b   Donnelly, Dorothy J ^c   McElhinney, R Stanley ^c   McMurry, T Brian H ^c   McCormick, Joan E ^c   Margison, Geoffrey P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 6 O BENZYLGUANINE; ALKYLATING AGENT; LOMEGUATRIB; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; ENZYME INACTIVATION; HUMAN; HUMAN TISSUE; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT; WEIGHT REDUCTION;

EID: 0034650791     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000115)85:2<248::AID-IJC16>3.0.CO;2-V     Document Type: Article

References (21)

1. 6-methylguanine-DNA methyltransferase activity in human tumors. Carcinogenesis, 13, 1503-1507 (1992).
2. 6-alkylguanine alkyltransferase (AT) in cancer chemotherapy. Cancer Treat. Rev., 15, 279-292 (1988).
3. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res., 51, 3367-3372 (1991).
4. 6-benzylguanine and its role in chemotherapy. Clin. Cancer Res., 3, 837-847 (1997).
5. 6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol., 46, 285-290 (1993).
6. 6-methylguanine-DNA methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N-nitro-N-nitrosoguanidine. Carcinogenesis, 5, 1641-1647 (1984).
7. 6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours. Brit. J. Cancer, 71, 37-39 (1995).
8. 6-benzylguanine increases the sensitivity of human primary bone marrow cells to the cytotoxic effects of temozolomide. Exp. Haematol., 23, 112-116 (1995).
9. JELINEK, J., KLEIBL, K., DEXTER, T.M. and MARGISON, G.P., Transfection of murine multi-potent haemopoietic stem cells with an E. coli DNA alkyltransferase gene confers resistance to the toxic effects of alkylating agents. Carcinogenesis, 9, 81-87 (1988).
10. LEE, S.M., MARGISON, G.P., WOODCOCK, A. and THATCHER, N., Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma. Brit. J. Cancer, 67, 1356-1360 (1993).
11. 6-alkylguanine-DNA alkyltransferase in human liver and melanoma. Brit. J. Cancer, 66, 355-360 (1992).
12. 6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide. Brit. J. Cancer, 69, 452-456 (1994).
13. MARGISON, G.P. and O'CONNOR, P.J., Biological consequences of reactions with DNA: role of specific lesions. In: C. Cooper and P. Grover (eds.), Handbook of Experimental Pharmacology, pp. 547-571, Springer-Verlag, Berlin (1990).
14. 6-(hetarylmethy)guanines having basic rings in the side-chain. J. med. Chem., 41, 5265-5271 (1998).
15. MICETICH, K.C., FUTSCHER, B.W., KOCH, D., FISHER, R.I. and ERICKSON, L.C., Phase I study of streptozocin-and carmustine-sequenced administration in patients with advanced cancer. J. nat. Cancer Inst., 84, 256-260 (1992).
16. MIDDLETON, M.R., GORE, M., TILGEN, W., FIERLBECK, G., GROB, J.J., THATCHER, N. and FRAASS, U., A randomized, phase III study of temozolomide (TMZ) versus dacarbazine (DTIC) in the treatment of patients with advanced, metastatic malignant melanoma. Proc. Amer. Soc. clin. Oncol., 19, (1999). Abstr. 2069.
17. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50, 6119-6129 (1990).
18. 6-benzylguanine (BG) plus carmustine (BCNU) in patients with advanced cancer. Proc. Amer. Soc. clin. Oncol., 17, 198a (1998).
19. 6-alkylguanine-DNA alkyltransferase. Clin. Cancer Res., 2, 1129-1134 (1996).
20. 6-alkylguanine-DNA alkyltransferase. Brit. J. Cancer, 74, 1030-1036 (1996).
21. 6-methylguanine as a free base. Cancer Res., 46, 1663-1668 (1986).